Drug
Lercanidipine
Lercanidipine: highest development phase Phase 2, developed by Recordati. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Recordati
Trials
| Drug | Phase | Indication |
|---|---|---|
| Lercanidipine NCT01093807 | Phase 2 | Essential Hypertension |
Latest
No recent events.
Follow Lercanidipine on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.